Trial · NCT01704287
Participant flow35
How many started, completed or left each group, period by period.
1 to 20 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Initial Treatment Period | STARTED | Pembrolizumab 2 mg/kg | 180 | |
| Initial Treatment Period | STARTED | Pembrolizumab 10 mg/kg | 181 | |
| Initial Treatment Period | STARTED | Investigator-Choice Chemotherapy (ICC) | 179 | |
| Initial Treatment Period | STARTED | ICC→Pembrolizumab 2 mg/kg | 0 | |
| Initial Treatment Period | STARTED | ICC→Pembrolizumab 10 mg/kg | 0 | |
| Initial Treatment Period | Treated | Pembrolizumab 2 mg/kg | 178 | |
| Initial Treatment Period | Treated | Pembrolizumab 10 mg/kg | 179 | |
| Initial Treatment Period | Treated | Investigator-Choice Chemotherapy (ICC) | 171 | |
| Initial Treatment Period | Treated | ICC→Pembrolizumab 2 mg/kg | 0 | |
| Initial Treatment Period | Treated | ICC→Pembrolizumab 10 mg/kg | 0 | |
| Initial Treatment Period | COMPLETED | Pembrolizumab 2 mg/kg | 33 | |
| Initial Treatment Period | COMPLETED | Pembrolizumab 10 mg/kg | 47 | |
| Initial Treatment Period | COMPLETED | Investigator-Choice Chemotherapy (ICC) | 6 | |
| Initial Treatment Period | COMPLETED | ICC→Pembrolizumab 2 mg/kg | 0 | |
| Initial Treatment Period | COMPLETED | ICC→Pembrolizumab 10 mg/kg | 0 | |
| Initial Treatment Period | NOT COMPLETED | Pembrolizumab 2 mg/kg | 147 | |
| Initial Treatment Period | NOT COMPLETED | Pembrolizumab 10 mg/kg | 134 | |
| Initial Treatment Period | NOT COMPLETED | Investigator-Choice Chemotherapy (ICC) | 173 | |
| Initial Treatment Period | NOT COMPLETED | ICC→Pembrolizumab 2 mg/kg | 0 | |
| Initial Treatment Period | NOT COMPLETED | ICC→Pembrolizumab 10 mg/kg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01704287/flow